Cidara Therapeutics Inc. (CDTX) Gained 12.2% or 0.5 To Price $4.6 On Monday


Cidara Therapeutics Inc. (CDTX) gained 12.2% or 0.5 to $4.6. It is close to 208021 shares traded, which is 111.57% compare to the average total volume 186444. The market cap of CDTX is $98.42 million. The year to date change is -41.01%. The 52 week price range is from $3.7 to $8.8. Price of CDTX have changed -5.75% during last week. It have changed 5.13% over last month, -38.35% over last 3 months, -45.70% over last 6 months and -44.59% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CDTX is 5.02. It is 9.13% above current price. The 200-day Moving Averages for CDTX is 6.67. It is 45.00% above current price. The 52-week High is 8.8. It is 91.30% from the current price. The 52-week Low is 3.7. It is -19.57% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of CDTX is 4.75 on 2018-04-30. Short % to float is 5.28%. There are some statistics of CDTX. It is has market cap $98.42 million. The share outstanding is 21.40 million. The average volume is 186444. It has 142.16M cash and 19.68M in debt. The percent of top 15 Institution holding is 80.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CDTX is -69.51%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CDTX is -55.44%.


Tags:

Share this post